These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 34793870)

  • 1. Yap-Sox9 signaling determines hepatocyte plasticity and lineage-specific hepatocarcinogenesis.
    Liu Y; Zhuo S; Zhou Y; Ma L; Sun Z; Wu X; Wang XW; Gao B; Yang Y
    J Hepatol; 2022 Mar; 76(3):652-664. PubMed ID: 34793870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sox9
    Tulasi DY; Castaneda DM; Wager K; Hogan CB; Alcedo KP; Raab JR; Gracz AD
    Cell Mol Gastroenterol Hepatol; 2021; 11(5):1437-1462. PubMed ID: 33497866
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Hill MA; Alexander WB; Guo B; Kato Y; Patra K; O'Dell MR; McCall MN; Whitney-Miller CL; Bardeesy N; Hezel AF
    Cancer Res; 2018 Aug; 78(16):4445-4451. PubMed ID: 29871934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hdac1 Regulates Differentiation of Bipotent Liver Progenitor Cells During Regeneration via Sox9b and Cdk8.
    Ko S; Russell JO; Tian J; Gao C; Kobayashi M; Feng R; Yuan X; Shao C; Ding H; Poddar M; Singh S; Locker J; Weng HL; Monga SP; Shin D
    Gastroenterology; 2019 Jan; 156(1):187-202.e14. PubMed ID: 30267710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TAZ is indispensable for c-MYC-induced hepatocarcinogenesis.
    Wang H; Zhang S; Zhang Y; Jia J; Wang J; Liu X; Zhang J; Song X; Ribback S; Cigliano A; Evert M; Liang B; Wu H; Calvisi DF; Zeng Y; Chen X
    J Hepatol; 2022 Jan; 76(1):123-134. PubMed ID: 34464659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOX9 acts downstream of YAP to decide liver cell fate and tumor types.
    Ding WX; Sancho-Bru P
    J Hepatol; 2022 Mar; 76(3):503-505. PubMed ID: 34929213
    [No Abstract]   [Full Text] [Related]  

  • 7. Yes-associated protein (YAP) induces a secretome phenotype and transcriptionally regulates plasminogen activator Inhibitor-1 (PAI-1) expression in hepatocarcinogenesis.
    Marquard S; Thomann S; Weiler SME; Bissinger M; Lutz T; Sticht C; Tóth M; de la Torre C; Gretz N; Straub BK; Marquardt J; Schirmacher P; Breuhahn K
    Cell Commun Signal; 2020 Oct; 18(1):166. PubMed ID: 33097058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NOTCH-YAP1/TEAD-DNMT1 Axis Drives Hepatocyte Reprogramming Into Intrahepatic Cholangiocarcinoma.
    Hu S; Molina L; Tao J; Liu S; Hassan M; Singh S; Poddar M; Bell A; Sia D; Oertel M; Raeman R; Nejak-Bowen K; Singhi A; Luo J; Monga SP; Ko S
    Gastroenterology; 2022 Aug; 163(2):449-465. PubMed ID: 35550144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice.
    Wang J; Dong M; Xu Z; Song X; Zhang S; Qiao Y; Che L; Gordan J; Hu K; Liu Y; Calvisi DF; Chen X
    Oncogene; 2018 Jun; 37(24):3229-3242. PubMed ID: 29545603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal tracing of Sox9+ liver progenitors in mouse oval cell injury.
    Tarlow BD; Finegold MJ; Grompe M
    Hepatology; 2014 Jul; 60(1):278-89. PubMed ID: 24700457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct and Overlapping Roles of Hippo Effectors YAP and TAZ During Human and Mouse Hepatocarcinogenesis.
    Wang H; Wang J; Zhang S; Jia J; Liu X; Zhang J; Wang P; Song X; Che L; Liu K; Ribback S; Cigliano A; Evert M; Wu H; Calvisi DF; Zeng Y; Chen X
    Cell Mol Gastroenterol Hepatol; 2021; 11(4):1095-1117. PubMed ID: 33232824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of Mothers Against Decapentaplegic Homolog 7 Activates the Yes-Associated Protein/NOTCH Cascade and Promotes Liver Carcinogenesis in Mice and Humans.
    Wang H; Song X; Liao H; Wang P; Zhang Y; Che L; Zhang J; Zhou Y; Cigliano A; Ament C; Superville D; Ribback S; Reeves M; Pes GM; Liang B; Wu H; Evert M; Calvisi DF; Zeng Y; Chen X
    Hepatology; 2021 Jul; 74(1):248-263. PubMed ID: 33368437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutive Notch2 signaling induces hepatic tumors in mice.
    Dill MT; Tornillo L; Fritzius T; Terracciano L; Semela D; Bettler B; Heim MH; Tchorz JS
    Hepatology; 2013 Apr; 57(4):1607-19. PubMed ID: 23175466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Context-Dependent Distinct Roles of SOX9 in Combined Hepatocellular Carcinoma-Cholangiocarcinoma.
    Park Y; Hu S; Kim M; Oertel M; Singhi A; Monga SP; Liu S; Ko S
    Cells; 2024 Aug; 13(17):. PubMed ID: 39273023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of hepatocyte identity following aberrant YAP activation: A key mechanism in alcoholic hepatitis.
    Bou Saleh M; Louvet A; Ntandja-Wandji LC; Boleslawski E; Gnemmi V; Lassailly G; Truant S; Maggiotto F; Ningarhari M; Artru F; Anglo E; Sancho-Bru P; Corlu A; Argemi J; Dubois-Chevalier J; Dharancy S; Eeckhoute J; Bataller R; Mathurin P; Dubuquoy L
    J Hepatol; 2021 Oct; 75(4):912-923. PubMed ID: 34129887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAT3 deficiency prevents hepatocarcinogenesis and promotes biliary proliferation in thioacetamide-induced liver injury.
    Abe M; Yoshida T; Akiba J; Ikezono Y; Wada F; Masuda A; Sakaue T; Tanaka T; Iwamoto H; Nakamura T; Sata M; Koga H; Yoshimura A; Torimura T
    World J Gastroenterol; 2017 Oct; 23(37):6833-6844. PubMed ID: 29085226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of trefoil factor 1 inhibits biliary regeneration but accelerates the hepatic differentiation of progenitor cells in mice.
    Hayashi Y; Yamaguchi J; Kokuryo T; Ebata T; Yokoyama Y; Nagino M
    Biochem Biophys Res Commun; 2018 Nov; 506(1):12-19. PubMed ID: 30333090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-Cell Analysis of the Liver Epithelium Reveals Dynamic Heterogeneity and an Essential Role for YAP in Homeostasis and Regeneration.
    Pepe-Mooney BJ; Dill MT; Alemany A; Ordovas-Montanes J; Matsushita Y; Rao A; Sen A; Miyazaki M; Anakk S; Dawson PA; Ono N; Shalek AK; van Oudenaarden A; Camargo FD
    Cell Stem Cell; 2019 Jul; 25(1):23-38.e8. PubMed ID: 31080134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YAP1 activation and Hippo pathway signaling in the pathogenesis and treatment of intrahepatic cholangiocarcinoma.
    Ko S; Kim M; Molina L; Sirica AE; Monga SP
    Adv Cancer Res; 2022; 156():283-317. PubMed ID: 35961703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive induction of hepatocyte progenitor cells in chronically injured liver.
    Tanimizu N; Ichinohe N; Yamamoto M; Akiyama H; Nishikawa Y; Mitaka T
    Sci Rep; 2017 Jan; 7():39990. PubMed ID: 28051157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.